To investigate the key role of TUBA1C in the pathogenesis of glioma, we selected the LN299 and U87 glioma cell lines as research subjects and used targeted siRNA-mediated knockdown technology to regulate the expression of TUBA1C (Figure 11A). Here, TUBA1C is linked to central nervous system cancer.